Search

Li Shi Phones & Addresses

  • Suwanee, GA
  • Rockville, MD
  • 6525 Stapleford Ln, Duluth, GA 30097
  • Norcross, GA
  • Corvallis, OR
  • Los Angeles, CA
  • Houston, TX
  • Mountain View, CA
  • West Lafayette, IN
  • Johns Creek, GA

Work

Company: Ge hitachi nuclear Apr 2012 Position: Nuclear i&c engineering consultant

Education

School / High School: Georgia Institute of Technology, School of Industrial and Systems Engineering- Atlanta, GA Jan 2009 Specialities: M.S. in Operations Research

Skills

Verification and Validation through Anal... • Hazard Analysis • Risk Analysis • Regression Analysis and Testing • Electrical power supply • heat load andresponse time calculations;... • System Validation • Subsystem Validation • Software Integration and Software Compon... • hypothesis testing • probability/PDF • Maximum Likelihood parameter estimation ... • Uncertainty Calculations. Reliability bl... • Markov • etc.).H/W and software reliability predi... • FITS • failure rate • availability • software reliability engineering • etc.) • Stochastic Process • Stochastic Optimization. TriStation1131 • SPACE • SIVAT • CAFTA • Monte Carlo Simulation using MCNP • C • Fortran • Matlab • Microsoft Office Products

Resumes

Resumes

Li Shi Photo 1

Senior Software Qa Analyst

View page
Location:
13500 Grenoble Dr, Rockville, MD 20853
Industry:
Computer Software
Work:
EMC Corporation (Acquired through Legato systems, Inc.) since 2004
Sr. QA Engineer

Legato Systems, Inc. (Acquired through OTG software, Inc) 2002 - 2004
QA Engineer

OTG Software 1999 - 2002
QA Engineer
Education:
University of Shanghai for Science and Technology 1987 - 1991
Skills:
Software Quality Assurance
Storage
Test Cases
Test Planning
Software Testing
Manual Testing
Regression Testing
Software Development
Software Development Life Cycle
Quality Assurance
Li Shi Photo 2

Independent Consultant

View page
Location:
10447 Nolan Dr, Rockville, MD 20850
Industry:
Biotechnology
Work:
Alpha Biometrics Consulting
Independent Consultant

Intercept Pharmaceuticals
Vp, Biostatistics and Data Management

Medimmune Jan 2005 - Aug 2018
Senior Director, Biostatistics

Shire Jan 1, 2000 - Dec 1, 2004
Associate Director

Iqvia 1993 - 2000
Manager
Education:
The Johns Hopkins University
Master of Science, Masters
University of Maryland
Bachelors, Bachelor of Science
Skills:
Writing
Logic
Consulting
Windows Server
Data Flow
Dreamweaver
Vendors
Rdbms
Sales
Community
Manages
Ecs
Shanghai
Visual Studio
Full Cycle
Oracle Database
Authentication
Converting
Biotechnology
Biostatistics
Ehr
Information System
Serving
Executive Positions
Indexes
Programming
Embedded Systems
Catalogs
Admin
Windows Xp
Cats
Assessment
Pets
Subscription
Dhtml
Database Triggers
Working Experience
Toys
Databases
Requirements Gathering
Back End
Management
Design
Human Capital
Computer Science
Outsourcing
Strip
Hp Enterprise Solutions
Programming Languages
Version Control
Data Backup
Mysql
Dol
Jsp
Information Systems
Alerts
Publications
Storefront
Accounting
Subscriptions
Linux
Client Side
Human Resources
Methodology
Preferences
Compass
Web Applications
Asp
Photoshop
Networking
Quotes
Robohelp
Casual
Languages
Manuals
System
Data Systems
Business Services
Cell
Frontpage
Real Time
Healthcare
Crystal Reports
Voice
Photography
Validation
Weblogic
Sage Act
Reports
Trace
Purchased
Skins
Inventory
Apache
T Sql
Visual Basic
Strategies
Mclean
Xml
Tables
Variables
Property
Transportation
Testing
Approval Process
Pl/Sql
Vss
Nasa
Hud
Rss
Feeds
Silver
Residence
News
Learner
Image
Intranet
Accessories
Decoration
Scripting
Contact Information
Documentation
Research
Reporting
Shares
Bls
Information Management
Mks
Payroll
Analysis
Written
Software Licensing
Advertising Agency
Concepts
.Net
Information Technology
Web Servers
Yahoo
C
Retail
Rights
Management System
Dns
Operating Systems
Query Writing
Applications
Web Design
Managerial Finance
Xslt
Social Housing
Communication
Home
Schedules
Web Development
Stored Procedures
Energy
User Requirements
Architectural Design
Html
Logic Programming
Pascal
Microsoft Access
Interactive Advertising
Server Configuration
Marketing
Sass
Mvc
Indexing
Erwin
Business Intelligence
Permissions
Technical Support
Microsoft Certified Professional
Data Logging
Project
Pages
Sql
Contractual Agreements
House
Delivers
Server Migration
Business Logic
Unix
Presentations
Flash
Websites
Responsibility
Internal Audit
Habits
Itc
Labor Issues
Data Warehousing
Pto
Purchasing
Intelligence
Sybase
Active Directory
Xsd
Start Ups
Korean
Interfaces
Blogging
Microsoft Sql Server
Business Rules
Government
Electronics
Iis
Tomcat
Integrated Marketing
Visio
Ajax
Software
Windows Nt
Asp.net
On Line
Financial Services
Oracle
Eclipse
Sccs
Satellite
Java
Test Cases
Watson
Network Communications
Independent Contributor
Microstrategy
Manufacturing
Asset
China
Javascript
C++
Invoicing
Visual Interdev
Software Development
Vbscript
Coldfusion
Employee Benefits
Schema
Storytelling
Interests:
Photograph
Cooking
Electronics
Home Improvement
Reading
Crafts
Gourmet Cooking
Home Decoration
Li Shi Photo 3

Operational Specialist

View page
Work:
Food2China
Operational Specialist
Li Shi Photo 4

Li Shi

View page
Location:
Washington, DC
Industry:
Management Consulting
Li Shi Photo 5

Li Shi

View page
Li Shi Photo 6

Li Shi

View page
Li Shi Photo 7

Li Shi

View page
Li Shi Photo 8

Akupunktor At Zhen Akupunktur Og Kinesisk Medisin

View page
Position:
Akupunktør at Zhen akupunktur og kinesisk medisin, Acupuncturist at Steiner
Location:
Tromso Area, Norway
Industry:
Alternative Medicine
Work:
Zhen akupunktur og kinesisk medisin - Tromsø, Norway since Aug 2012
Akupunktør

Steiner since Sep 1997
Acupuncturist

Steiner Leisure Limited Sep 2007 - Oct 2008
Acupuncturist
Education:
Atlantic Institute of Oriental Medicine 2004 - 2007
BA, Oriental Medicine
Atlantic Institute of Oriental Medicine 2004 - 2007
Master, Oriental Medicine
Florida Atlantic University 2000 - 2004
BA, Finance
Florida Atlantic University 2000 - 2004
BA, Health Administration

Business Records

Name / Title
Company / Classification
Phones & Addresses
Li Shi
Secretary
ATLANTECH COMPUTER TRAINING CENTERS, INC
3651 Peachtree Pkwy SUITE E, Suwanee, GA
Li Shi
Principal
NIUCLAIRE LLC
Nonclassifiable Establishments
2331 Maynard Rd, Charlotte, NC 28270
5150 Edgerton Dr, Norcross, GA 30092

Publications

Us Patents

Anti-Pd-L1 Antibody Treatment Of Bladder Cancer

View page
US Patent:
20220332828, Oct 20, 2022
Filed:
Apr 14, 2022
Appl. No.:
17/720903
Inventors:
- GAITHERSBURG MD, US
JOHN ANDREW BLAKE-HASKINS - GAITHERSBURG MD, US
MAGDALENA ZAJAC - CAMBRIDGE, GB
MARLON REBELATTO - GAITHERSBURG MD, US
ASHOK GUPTA - GAITHERSBURG MD, US
TONY HO - GAITHERSBURG MD, US
JILL WALKER - CAMBRIDGE, GB
XIAOPING JIN - GAITHERSBURG MD, US
SHANNON MORRIS - GAITHERSBURG MD, US
ROBERT IANNONE - GAITHERSBURG MD, US
LI SHI - GAITHERSBURG MD, US
MOHAMMED DAR - GAITHERSBURG MD, US
YONG BEN - GAITHERSBURG MD, US
International Classification:
C07K 16/28
A61P 35/00
A61K 9/00
G01N 33/542
Abstract:
Provided are methods of treating bladder cancer (e.g., urothelial carcinoma, UC) in a subject having bladder cancer, e.g., UC, with an effective dose regimen of an anti-PD-L1 antibody, e.g., durvalumab, or an antigen binding fragment thereof. Also provided are methods in which an anti-PD-L1 antibody is used in combination with another immunotherapeutic agent, e.g., tremelimumab to treat a bladder cancer, e.g., UC, in a subject having bladder cancer. In some cases, the subject undergoing treatment is identified as having a bladder cancer or tumor that is PD-L1-low/neg, or PD-L1-high. Methods are also provided in which anti-PD-L1 antibody treatment of bladder cancer is used following a standard of care or first-line therapy in subjects who have progressed following such therapies or who have relapsed after a prior treatment regimen.

Anti-Pd-L1 Antibody Treatment Of Bladder Cancer

View page
US Patent:
20190359715, Nov 28, 2019
Filed:
Feb 16, 2018
Appl. No.:
16/486222
Inventors:
- GAITHERSBURG MD, US
JOHN ANDREW BLAKE-HASKINS - GAITHERSBURG MD, US
MAGDALENA ZAJAC - CAMBRIDGE, GB
MARLON REBELATTO - GAITHERSBURG MD, US
ASHOK GUPTA - GAITHERSBURG MD, US
TONY HO - GAITHERSBURG MD, US
JILL WALKER - CAMBRIDGE, GB
XIAOPING JIN - GAITHERSBURG MD, US
SHANNON MORRIS - GAITHERSBURG MD, US
ROBERT IANNONE - GAITHERSBURG MD, US
LI SHI - GAITHERSBURG MD, US
MOHAMMED DAR - GAITHERSBURG MD, US
YONG BEN - GAITHERSBURG MD, US
International Classification:
C07K 16/28
A61K 9/00
G01N 33/542
A61P 35/00
Abstract:
Provided are methods of treating bladder cancer (e.g., urothelial carcinoma, UC) in a subject having bladder cancer, e.g., UC, with an effective dose regimen of an anti-PD-L1 antibody, e.g., durvalumab, or an antigen binding fragment thereof. Also provided are methods in which an anti-PD-L1 antibody is used in combination with another immunotherapeutic agent, e.g., tremelimumab to treat a bladder cancer, e.g., UC, in a subject having bladder cancer. In some cases, the subject undergoing treatment is identified as having a bladder cancer or tumor that is PD-L1-low/neg, or PD-L1-high. Methods are also provided in which anti-PD-L1 antibody treatment of bladder cancer is used following a standard of care or first-line therapy in subjects who have progressed following such therapies or who have relapsed after a prior treatment regimen.

Anti-B7-H1 Antibodies For Treating Tumors

View page
US Patent:
20190338033, Nov 7, 2019
Filed:
May 21, 2019
Appl. No.:
16/418488
Inventors:
- CAMBRIDGE, GB
David Fairman - Cambridge, GB
Paul Robbins - Gaithersburg MD, US
Meina Liang - Gaithersburg MD, US
Amy Schneider - Gaithersburg MD, US
Carlos Chavez - Gaithersburg MD, US
Carina Herl - Gaithersburg MD, US
Min Pak - Gaithersburg MD, US
Hong Lu - Gaithersburg MD, US
Marlon Rebelatto - Gaithersburg MD, US
Keith Steele - Gaithersburg MD, US
Anmarie Boutrin - Gaithersburg MD, US
Li Shi - Gaithersburg MD, US
Shengyan Hong - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Lorin Roskos - Gaithersburg MD, US
International Classification:
C07K 16/28
C07K 16/30
G01N 33/574
Abstract:
Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.

Anti-B7-H1 Antibodies For Treating Tumors

View page
US Patent:
20160222120, Aug 4, 2016
Filed:
Sep 11, 2014
Appl. No.:
15/021161
Inventors:
- Cambridgeshire, GB
David Fairman - Cambridge, GB
Paul Robbins - Gaithersburg MD, US
Meina Liang - Gaithersburg MD, US
Amy Schneider - Gaithersburg MD, US
Carlos Chavez - Gaithersburg MD, US
Carina Herl - Gaithersburg MD, US
Min Pak - Gaithersburg MD, US
Hong Lu - Gaithersburg MD, US
Marlon Rebelatto - Gaithersburg MD, US
Keith Steele - Gaithersburg MD, US
Anmarie Boutrin - Gaithersburg MD, US
Li Shi - Gaithersburg MD, US
Shengyan Hong - Gaithersburg MD, US
Brandon Higgs - Gaithersburg MD, US
Lorin Roskos - Gaithersburg MD, US
Assignee:
Medlmmune Limited - Cambridge
International Classification:
C07K 16/28
G01N 33/574
C07K 16/30
Abstract:
Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.

Combination Therapy For Pd-L1 Negative Tumors

View page
US Patent:
20160060344, Mar 3, 2016
Filed:
Aug 28, 2015
Appl. No.:
14/838650
Inventors:
Rajesh Narwal - Gaithersburg MD, US
Marlon C. Rebelatto - Gaithersburg MD, US
Keith Steele - Gaithersburg MD, US
Paul Robbins - Gaithersburg MD, US
Ross Anthony Stewart - Cambridge, GB
John A. Blake-Haskins - Gaithersburg MD, US
Joyson J. Karakunnel - Gaithersburg MD, US
Ramy Ibrahim - Gaithersburg MD, US
Aiman Shalabi - Gaithersburg MD, US
Alessandra Di Pietro - Gaithersburg MD, US
Li Shi - Gaithersburg MD, US
Shengyan Hong - Gaithersburg MD, US
Paul Stockman - Alderley Park, GB
Marc Ballas - Gaithersburg MD, US
Mohammed M. Dar - Gaithersburg MD, US
International Classification:
C07K 16/28
Abstract:
The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and tremelimumab in a subject identified as having a PD-L1 negative tumor.

Wikipedia References

Li Shi Photo 9

Li Shi

Work:
Position:

Model • Mayor • Justice • Chancellor • Governor • Magistrate

Business category:

Governors • Salt

Education:
Specialty:

Director • Modern historian

Skills & Activities:
Master status:

Empress

Preference:

Associate • Treason

Li Shi Photo 10

Li Shi

Work:

Li Shi { cellpadding 3px cellspacing 0px bgcolor #f7f8ff style " float: right; border: 2px solid; margin: 5px; "! align center style " background: #ccf; border-bottom: 2px solid " colspan 2 " Guiyihou " ( 歸義侯 ) " Li Shi " ( 李勢 ) ( died 361 ), courtesy name " Ziren " ( 子仁 ), historically known by his Jin Dynasty ( 265-420 ) -bestowed title " Marquess of Guiyi " ( 歸義侯 ), was the last emperor of the History of China Ba ( state ) -Di ( Wu Hu ) state Cheng Han
As Li Shou was a cousin of Cheng Han's founding emperor Li Xiong and an honored general, Li Shi himself was an army officer, and he was much favored by the emperor Li Qi ( emperor ),.

Education:

During his reign, the Cheng Han state continued the deterioration that occurred through his father Li Shou's reign, and in 347, Li Shi's forces failed against the Jin expedition force commanded by Huan Wen.

Skills & Activities:
Master status:

Empress • Tribal

Isbn (Books And Publications)

Inequality and Public Policy in China

View page
Author

Li Shi

ISBN #

0521870453

Zhongguo Miao Zu Zhe Xue She Hui Si Xiang Shi: Zhong Guo Miao Zu Zhe Xue She Hui Si Xiang Shi

View page
Author

Li Shi

ISBN #

7221070652

Li W Shi from Suwanee, GA, age ~64 Get Report